We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cocoa May Help Suppress Colon Cancer

By LabMedica International staff writers
Posted on 14 Feb 2012
Print article
A new study on living lab rats has shown for the first time that eating cocoa can help prevent intestinal disorders associated with oxidative stress, including colon carcinogenesis onset caused by chemical compounds.

The growing interest among the scientists to identify those foods capable of preventing diseases has now branded cocoa as a “superfood.” It has been recognized as an excellent source of phytochemical compounds, which offer potential health benefits.

Led by scientists from the Institute of Food Science and Technology and Nutrition (ICTAN; Madrid, Spain) and published in the December 2011 issue of the Molecular Nutrition & Food Research journal, the new study supports this hypothesis and maintains the claim that cacao consumption helps to prevent intestinal problems associated oxidative stress, such as the onset of chemically induced colon carcinogenesis.

“Being exposed to different poisons in the diet like toxins, mutagens, and procarcinogens, the intestinal mucus is very susceptible to pathologies,” explained Dr. María Ángeles Martín Arribas, lead author of the study and researcher at ICTAN. She added that, “foods like cocoa, which is rich in polyphenols, seems to play an important role in protecting against disease.”

The study on live rats has validated, for the first time, the potential protection effect that flavonoids in cocoa have against colon cancer onset. For eight weeks, the scientists of the study fed the rats with a cocoa-rich (12%) diet and carcinogenesis was induced.

Dr. Martín Arribas reported that, “four weeks after being administered with the chemical compound azoxymethane [AOM], intestinal mucus from premalignant neoplastic lesions appeared. These lesions are called ‘aberrant crypt foci’ and are considered to be good markers of colon cancer pathogenesis.”

The study’s findings revealed that the rats fed a cocoa-rich diet had a considerably reduced number of aberrant crypt foci in the colon induced by the carcinogen. Similarly, this sample saw an improvement in their endogenous antioxidant defenses and a decrease in the markers of oxidative damage induced by the toxic compound in this cell.

The researchers concluded that the protection effect of cocoa can block cell-signaling pathways involved in cell proliferation, and therefore, subsequent neoplasty and tumor formation. Lastly, the animals fed with the cocoa-rich diet showed an increase in apoptosis as a chemoprevention process against the development of the carcinogenesis.

Although more research is required to determine what bioactive compounds in cocoa are responsible for such effects, the authors concluded that a cocoa-rich diet seems capable of reducing induced oxidative stress. It could also have protection properties in the initial stages of colon cancer as it reduces premalignant neoplastic lesion formation.

Cocoa is one of the chief ingredients in chocolate. It is one of the richest foods in phenolic compounds, mainly in flavonoids such as procyanidins, catechins, and epicatechins, which have numerous beneficial biologic activities in the prevention of cardiovascular diseases and cancer (mainly colorectal cancer).

In fact, compared to other foods with high flavonoid content, cocoa has a high level of procyanidins with limited bioavailability. These flavonoids are therefore found in their highest concentrations in the intestine where they neutralize many oxidants.


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Automated Blood Typing System
IH-500 NEXT
New
Hepato Fibrosis Assays
Hepato Fibrosis Assays
New
Automated Cell Counter
QuadCount

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.